Should Familial or Early-Onset HUVS Get DNASE1L3 Testing?

DNASE1L3 genetic testing is not a routine part of diagnosing standard Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS) in adults. Typical HUVS is generally not considered an inherited disease. However, genetic testing is an important consideration for a specific, rare subset of patients—particularly those whose symptoms began in childhood, who have unusually severe kidney involvement, or who have multiple family members with HUVS or lupus-like conditions.

In these specific cases, a rare inherited condition related to the DNASE1L3 gene can mimic or overlap with HUVS. Discovering a pathogenic variant (a gene change known to impair function) can support a genetic diagnosis and help guide family counseling, though it does not automatically dictate a specific medical treatment ^[1][2].

The Connection Between HUVS and the DNASE1L3 Gene

The DNASE1L3 gene provides instructions for making an enzyme that helps clear out dead cells and cellular debris (like stray pieces of DNA) from the bloodstream ^[3]. When this gene does not work properly, cellular waste can build up. The immune system may mistakenly identify this debris as a threat and create autoantibodies (proteins that attack the body’s own tissues) ^[2].

This immune response can lead to widespread inflammation and low complement levels (immune proteins measured in the blood) ^[1]. People with DNASE1L3 deficiency do not all have the exact same symptoms ^[2]. Some develop a condition that strongly resembles HUVS, with hives and low complement ^[2]. Others develop systemic lupus erythematosus (SLE) or a severe overlap of both conditions ^[3][2]. It is important to understand that having hives and low complement does not mean you have a DNASE1L3 deficiency; classic HUVS is a separate, non-inherited condition.

When Should Genetic Testing Be Considered?

Because DNASE1L3-related conditions are very rare, testing is not necessary for most people diagnosed with HUVS. A medical geneticist (a doctor specializing in inherited diseases) or a rheumatologist generally reserves this testing for situations where specific “red flags” suggest a rare inherited immune disorder:

• Childhood or Early Onset: If symptoms of HUVS or a severe lupus-like illness began during childhood or early adolescence, genetic testing is more likely to be considered ^[4][1].
• Family History: Cases where multiple siblings or relatives have been diagnosed with HUVS, lupus, or unexplained kidney disease suggest a possible inherited link ^[5][6].
• Consanguinity: If the patient’s parents are closely related by blood, the chance of inheriting a rare genetic condition is higher ^[7].
• Unusual Kidney Involvement: DNASE1L3-associated disease is frequently associated with nephritis (inflammation of the kidneys) ^[2]. Testing may be considered if kidney involvement is unusually severe, starts very early, or is accompanied by other severe complications ^[4][8].

Important Safety Note: Genetic testing can take weeks or months. It should never delay urgent evaluation or treatment. Seek immediate medical attention if you experience symptoms like coughing or vomiting blood, new or worsening shortness of breath, markedly reduced urine, visible blood in the urine, or rapidly increasing swelling.

Understanding Genetic Testing and Results

Genetic testing usually involves a blood or saliva sample. Doctors may use a targeted panel (testing a specific group of genes related to immune disorders) or whole-exome sequencing (looking at most of the protein-coding genes in your DNA) ^[7][3].

DNASE1L3-related disease is inherited in an autosomal recessive pattern ^[6]. This means a person must inherit two pathogenic variants—one from each parent (called biallelic)—to develop the disease ^[7][1].

What the Results Mean

• Positive Result: Finding biallelic pathogenic variants in the DNASE1L3 gene supports a genetic diagnosis ^[1]. While it does not predict your exact future symptoms or dictate a single standard treatment, it may prompt your doctor to establish a tailored plan for monitoring your kidney function and other organs ^[2][8].
• Negative Result: A negative test does not completely rule out a genetic cause. Other genes or variants not detected by the specific testing method used may still be involved.
• Variant of Uncertain Significance (VUS): Sometimes testing finds a change in the gene, but there isn’t enough scientific evidence to know if it causes disease ^[1]. A VUS should not be used alone to diagnose a patient or to guide predictive testing for relatives ^[9].

Family Planning and Relatives

Because of the recessive inheritance pattern, parents of an affected person are usually “carriers” (having one working gene and one variant) and typically do not have the disease.

• Siblings: When both parents are carriers, for each pregnancy, a sibling has a 25% chance of inheriting both variants and being at risk for the disease, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant ^[6][7].
• Future Children: An affected person will pass one pathogenic variant to all of their children. However, a child will only be at risk for the disease if the other biological parent is also a carrier.

A genetic counselor can help you understand these risks, discuss privacy and insurance considerations, and determine if targeted testing is appropriate for your relatives ^[7].